Thursday, May 11, 2006
RCP Diagnostics Licenses Technology
Phoenix, Arizona-based RCP Diagnostics announced this morning that it has licensed its protein marker, for use in a blood diagnostic test for breast cancer. RCP said that it has licensed its protein marker to fellow Arizona firm Biomarker Technologies, which is developing a blood test for identifying cancer based on biomarkers. Financial terms were not disclosed. The licensing covers Biomarker's use of RCP's marker only for the diagnosis of breast cancer.